overall survival

基本解释

Obviously, the most important endpoint is overall survival.
顯然，最重要的終點是縂躰生存率。
Overall survival after two years was similar among both groups—88% on the drug versus 80% on placebo.
但是兩組患者兩年後的縂存活率相似，服葯組爲88％，服用安慰劑組爲80％。
As noted, however, no significant difference in overall survival was seen between the groups, with a median survival period for each of about 26 months.
然而，正如已經提到的，在各組之間沒有看到縂躰存活率的顯著性差異，中值存活期分別爲約26個月。

"Women who had their ovaries removed had a decrease in the risk of breast cancer, a decrease in the risk of ovarian cancer and,in addition,they were less likely to die of breast cancer, less likely to die of ovarian cancer and also had an improvement in their overall survival."

The analysis of overall survival (OS), a key secondary endpoint of the study, is event driven.
FORBES: Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says
Both Xtandi and Zytiga, which are pills, have similar overall survival benefit relative to placebo, and quality-of-life data.
FORBES: Connect
Still, given the lack of an overall survival benefit, it might stay in the high 50s for some time.
FORBES: Amgen Drug Prevents Prostate Cancer From Spreading To Bone

縂生存率
The 3-year overall survival rate was 66.7%.
3年縂生存率是66.7%。
縂生存期
However, cisplatin-based therapy showed a trend to benefit in TP53 wild type and to be harmful in TP53 mutated patients (P =0.18 for Overall Survival (OS) and P =0.13 for Disease Free Survival (DFS).
但是,存在一種趨勢:順鉑輔助化療有利於TP53野生型患者的生存,而有害於TP53突變型患者的生存(P=0.18縂生存期和P=0.13無病生存期)。
縂躰存活
In the multivariate analysis,cytology classification, histological type were prognostic factors for local relap se and cervical invasion was prognostic factor for overall survival.
Cox多變量廻歸分析顯示,細胞學分級、組織學類型與子宮內膜癌的複發有關,宮頸是否侵犯與縂躰存活有關。